NO20084632L - Nye krystaller av 3-[5-[4-(cyclopentyloksy)-2-hydroksybenzoyl]-2-[(3-hydroksy-1,2-benzisoksazol-6-yl)metoksy]-fenyl]propion syre - Google Patents
Nye krystaller av 3-[5-[4-(cyclopentyloksy)-2-hydroksybenzoyl]-2-[(3-hydroksy-1,2-benzisoksazol-6-yl)metoksy]-fenyl]propion syreInfo
- Publication number
- NO20084632L NO20084632L NO20084632A NO20084632A NO20084632L NO 20084632 L NO20084632 L NO 20084632L NO 20084632 A NO20084632 A NO 20084632A NO 20084632 A NO20084632 A NO 20084632A NO 20084632 L NO20084632 L NO 20084632L
- Authority
- NO
- Norway
- Prior art keywords
- hydroxybenzoyl
- cyclopentyloxy
- hydroxy
- propionic acid
- benzisoxazol
- Prior art date
Links
- 239000013078 crystal Substances 0.000 title abstract 3
- DALCQQSLNPLQFZ-UHFFFAOYSA-N 3-[5-(4-cyclopentyloxy-2-hydroxybenzoyl)-2-[(3-oxo-1,2-benzoxazol-6-yl)methoxy]phenyl]propanoic acid Chemical compound C=1C=C(OCC=2C=C3ON=C(O)C3=CC=2)C(CCC(=O)O)=CC=1C(=O)C(C(=C1)O)=CC=C1OC1CCCC1 DALCQQSLNPLQFZ-UHFFFAOYSA-N 0.000 title abstract 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 abstract 2
- QLDQYRDCPNBPII-UHFFFAOYSA-N 1,2-benzoxazol-3-one Chemical compound C1=CC=C2C(O)=NOC2=C1 QLDQYRDCPNBPII-UHFFFAOYSA-N 0.000 abstract 1
- 239000008186 active pharmaceutical agent Substances 0.000 abstract 1
- 239000003435 antirheumatic agent Substances 0.000 abstract 1
- 125000001887 cyclopentyloxy group Chemical group C1(CCCC1)O* 0.000 abstract 1
- 230000005611 electricity Effects 0.000 abstract 1
- 238000000634 powder X-ray diffraction Methods 0.000 abstract 1
- 235000019260 propionic acid Nutrition 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/12—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2006146220 | 2006-05-26 | ||
| PCT/JP2007/060670 WO2007138996A1 (ja) | 2006-05-26 | 2007-05-25 | ３－｛５－［４－（シクロペンチルオキシ）－２－ヒドロキシベンゾイル］－２－［（３－ヒドロキシ－１，２－ベンズイソオキサゾール－６－イル）メトキシ］フェニル｝プロピオン酸の新規な結晶 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20084632L true NO20084632L (no) | 2008-12-12 |
Family
ID=38778516
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20084632A NO20084632L (no) | 2006-05-26 | 2008-11-04 | Nye krystaller av 3-[5-[4-(cyclopentyloksy)-2-hydroksybenzoyl]-2-[(3-hydroksy-1,2-benzisoksazol-6-yl)metoksy]-fenyl]propion syre |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US7977492B2 (pl) |
| EP (1) | EP2022788B1 (pl) |
| JP (1) | JP5117381B2 (pl) |
| KR (1) | KR101389038B1 (pl) |
| CN (1) | CN101454298B (pl) |
| AT (1) | ATE479666T1 (pl) |
| AU (1) | AU2007268771B2 (pl) |
| BR (1) | BRPI0712909A2 (pl) |
| CA (1) | CA2652939C (pl) |
| CY (1) | CY1111398T1 (pl) |
| DE (1) | DE602007008882D1 (pl) |
| DK (1) | DK2022788T3 (pl) |
| EC (1) | ECSP089000A (pl) |
| ES (1) | ES2351065T3 (pl) |
| HR (1) | HRP20100544T1 (pl) |
| IL (1) | IL195416A (pl) |
| MA (1) | MA30510B1 (pl) |
| MX (1) | MX2008014906A (pl) |
| NO (1) | NO20084632L (pl) |
| NZ (1) | NZ573034A (pl) |
| PL (1) | PL2022788T3 (pl) |
| PT (1) | PT2022788E (pl) |
| RS (1) | RS51517B (pl) |
| RU (1) | RU2429233C2 (pl) |
| SI (1) | SI2022788T1 (pl) |
| WO (1) | WO2007138996A1 (pl) |
| ZA (1) | ZA200809922B (pl) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2562170T3 (pl) * | 2006-02-21 | 2015-03-31 | Toyama Chemical Co Ltd | Sposób wytwarzania estru kwasu 3-{5-[4-(cyklopentyloksy)- 2-hydroksybenzoilo]-2-[(3-okso-2-podstawionego-2,3-dihydro-1,2-benzizoksazol-6-ilo)metoksy]fenylo}- propionowego i związku pośredniego dla sposobu |
| NZ588128A (en) * | 2008-03-27 | 2012-12-21 | Toyama Chemical Co Ltd | USE OF BENZOPHENONE DERIVATIVE OR SALT THEREOF AND TNF alpha INHIBITOR IN COMBINATION AND PHARMACEUTICAL COMPOSITION CONTAINING THE DERIVATIVE OR SALT THEREOF AND THE INHIBITOR |
| CN102014889A (zh) | 2008-04-22 | 2011-04-13 | 富山化学工业株式会社 | 组合使用二苯甲酮衍生物或其盐和免疫抑制剂的方法以及包含这些组分的药物组合物 |
| CN103183647B (zh) * | 2011-12-28 | 2017-06-09 | 天津市国际生物医药联合研究院有限公司 | 3‑{[2‑[3‑氧‑(1,2‑苯并异噻唑‑6‑基)甲氧基‑5‑(2‑羟基‑4‑环戊氧基苯甲酰基)]苯基}丙酸的制备方法 |
| CN118255728B (zh) * | 2024-01-25 | 2024-07-30 | 中国医学科学院阜外医院 | 化合物的盐型晶型用于治疗射血分数保留的心衰的用途 |
| CN118252824B (zh) * | 2024-01-25 | 2024-09-17 | 中国医学科学院阜外医院 | 化合物用于治疗射血分数保留的心衰的用途 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3042150A (en) | 1960-01-26 | 1962-07-03 | Lukawsky Michael | Emergency brake and anti-skid device |
| WO1995001964A1 (fr) * | 1993-07-06 | 1995-01-19 | Yamanouchi Pharmaceutical Co., Ltd. | Nouveau cristal de derive de benzodiazepine |
| AU769778B2 (en) * | 1998-11-05 | 2004-02-05 | Toyama Chemical Co. Ltd. | Novel compounds and pharmaceutical use thereof |
| JP4976617B2 (ja) * | 2000-03-17 | 2012-07-18 | 富山化学工業株式会社 | 新規なベンゾフェノン誘導体およびその塩 |
| JP4554926B2 (ja) | 2001-11-16 | 2010-09-29 | 富山化学工業株式会社 | 新規なベンゾフェノン誘導体またはその塩 |
-
2007
- 2007-05-25 RU RU2008151778/04A patent/RU2429233C2/ru not_active IP Right Cessation
- 2007-05-25 SI SI200730416T patent/SI2022788T1/sl unknown
- 2007-05-25 AT AT07744104T patent/ATE479666T1/de active
- 2007-05-25 DE DE602007008882T patent/DE602007008882D1/de active Active
- 2007-05-25 NZ NZ573034A patent/NZ573034A/en not_active IP Right Cessation
- 2007-05-25 ES ES07744104T patent/ES2351065T3/es active Active
- 2007-05-25 KR KR1020087029846A patent/KR101389038B1/ko not_active IP Right Cessation
- 2007-05-25 JP JP2008517894A patent/JP5117381B2/ja not_active Expired - Fee Related
- 2007-05-25 PT PT07744104T patent/PT2022788E/pt unknown
- 2007-05-25 MX MX2008014906A patent/MX2008014906A/es active IP Right Grant
- 2007-05-25 AU AU2007268771A patent/AU2007268771B2/en not_active Ceased
- 2007-05-25 CN CN2007800193483A patent/CN101454298B/zh not_active Expired - Fee Related
- 2007-05-25 WO PCT/JP2007/060670 patent/WO2007138996A1/ja active Application Filing
- 2007-05-25 PL PL07744104T patent/PL2022788T3/pl unknown
- 2007-05-25 RS RSP-2010/0522A patent/RS51517B/en unknown
- 2007-05-25 EP EP07744104A patent/EP2022788B1/en active Active
- 2007-05-25 CA CA2652939A patent/CA2652939C/en not_active Expired - Fee Related
- 2007-05-25 DK DK07744104.6T patent/DK2022788T3/da active
- 2007-05-25 US US12/302,375 patent/US7977492B2/en not_active Expired - Fee Related
- 2007-05-25 BR BRPI0712909-2A patent/BRPI0712909A2/pt not_active IP Right Cessation
-
2008
- 2008-11-04 NO NO20084632A patent/NO20084632L/no unknown
- 2008-11-20 ZA ZA2008/09922A patent/ZA200809922B/en unknown
- 2008-11-20 IL IL195416A patent/IL195416A/en not_active IP Right Cessation
- 2008-12-12 MA MA31468A patent/MA30510B1/fr unknown
- 2008-12-23 EC EC2008009000A patent/ECSP089000A/es unknown
-
2010
- 2010-10-05 HR HR20100544T patent/HRP20100544T1/hr unknown
- 2010-12-01 CY CY20101101102T patent/CY1111398T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20084632L (no) | Nye krystaller av 3-[5-[4-(cyclopentyloksy)-2-hydroksybenzoyl]-2-[(3-hydroksy-1,2-benzisoksazol-6-yl)metoksy]-fenyl]propion syre | |
| EA201300231A1 (ru) | Способ проектирования инкрементального счетчика доз для ингалятора, компьютерный способ его проектирования и способ их серийного производства | |
| SI2576523T1 (sl) | Kristalinične oblike 4-(5-(3-kloro-5-(trifluorometil)fenil)-4,5-dihidro 5-(trifluorometil)-3-izoksazolil)-N-(2-okso-2-((2,2,2-trifluoroetil) amino)etil)-1 naftalenkarboksamida | |
| WO2008133290A1 (ja) | 重合性液晶化合物、重合性液晶組成物、液晶性高分子および光学異方体 | |
| WO2005034952A3 (en) | Isoxazole and isothiazole compounds useful in the treatment of inflammation | |
| EA201070242A1 (ru) | Инъекционное устройство | |
| WO2010036506A3 (en) | Interchangable access device for a dispenser | |
| FR2967344B1 (fr) | Dispositif pour l'injection d'un ciment osseux comprenant un systeme de blocage de sur-pression | |
| WO2008009924A3 (en) | Indoles useful in the treatment of inflammation | |
| WO2004008849A3 (en) | Synergistically acting herbicidal mixtures | |
| NO20100363L (no) | Rotasjonsmekanisme | |
| UA102539C2 (ru) | Производные оксадиазола, активные в отношении сфингозин-1-фосфата (s1p) | |
| NO20083374L (no) | Spylehode | |
| WO2012036384A3 (ko) | 낚시용 릴의 브러쉬 브레이크장치 | |
| ATE518935T1 (de) | Optisch isotropes flüssigkristallmedium und optische vorrichtung | |
| PE20080554A1 (es) | Formulacion acuosa del acido 4-[((4-carboxibutil)-{2-[(4-fenetilbencil)oxi]fenil}amino)metil]benzoico | |
| MX2009004363A (es) | Dispositivo de inclinacion de collar para accionador de valvula. | |
| DE602008000780D1 (de) | Kraftfahrzeugklimaanlagemischluftstromverteilvorrichtung | |
| BRPI0606178A2 (pt) | derivados de 3-aril-1,2-benzisoxazol e sua utilização como medicamentos contra o cáncer | |
| ZA202404192B (en) | Naphthalene isoxazoline compound and application thereof | |
| Ting et al. | Nonlinear Hysteresis Control System | |
| Jankiewicz et al. | A Triradical Cation: Reactivity Studies of the 2, 4, 6-Tridehydropyridinium Ion | |
| TH126087B (th) | สูตรตำรับที่ใช้ทางปากชนิดของแข็งและรูปผลึกของตัวยับยั้งของอะพอพโทซิส โปรตีน (inhibitor of apoptosis protein) | |
| KR20130007708A (ko) | 약먹은 경과시간을 알려주는 약상자 |